BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10634182)

  • 41. High dose therapy and autologous bone marrow versus blood cell rescue. South Island Bone Marrow Transplant Unit.
    Hill GR; Inder A; Patton WN; Hart DN
    N Z Med J; 1996 Feb; 109(1016):45-8. PubMed ID: 8598936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inadequate red cell depletion of large-volume marrow harvests processed on the Fenwal CS-3000 Plus.
    Gremba C; Tarosky T; Rosenfeld CS
    J Hematother; 1994; 3(3):225-7. PubMed ID: 7827871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful blood stem cell collection and transplant in children weighing less than 25 kg.
    Deméocq F; Kanold J; Chassagne J; Bezou MJ; Lutz P; deLumley L; Philip I; Vannier JP; Margueritte G; Lamagnére JP
    Bone Marrow Transplant; 1994 Jan; 13(1):43-50. PubMed ID: 7912601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Processing of equine bone marrow using the automated MarrowXpress System: RBC depletion, volume reduction, and mononuclear cell recovery.
    Owens SD; Burges J; Johns JL; Carrade DD; Galuppo LD; Librach F; Borjesson DL
    Vet Clin Pathol; 2011 Dec; 40(4):444-449. PubMed ID: 22092275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
    Richel DJ; Baars JW; Wijngaarden MJ; van der Schoot CE; Vlasveld LT; Rodenhuis S
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):245-50. PubMed ID: 7679478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of short G-CSF administration on the numbers and clonogenic efficiency of hematopoietic progenitor cells in bone marrow and peripheral blood of normal donors.
    Zaucha JM; Knopińska-Posłuszny W; Bieniaszewska M; Myśliwski A; Hellmann A
    Ann Transplant; 2000; 5(4):20-6. PubMed ID: 11499355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automated processing of human bone marrow grafts for transplantation.
    Zingsem J; Zeiler T; Zimmermanm R; Weisbach V; Mitschulat H; Schmid H; Beyer J; Siegert W; Eckstein R
    Vox Sang; 1993; 65(4):293-9. PubMed ID: 8310681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
    Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
    Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Processing of major ABO-incompatible bone marrow for transplantation by using dextran sedimentation.
    Tsang KS; Li CK; Wong AP; Leung Y; Lau TT; Li K; Shing MM; Chik KW; Yuen PM
    Transfusion; 1999; 39(11-12):1212-9. PubMed ID: 10604248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Red cell salvage and reinfusion in pediatric bone marrow donors.
    Kletzel M; Olszewski M; Danner-Koptik K; Coyne K; Haut P
    Bone Marrow Transplant; 1999 Aug; 24(4):385-8. PubMed ID: 10467327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
    Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
    Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone marrow processing with the AMICUS™ separator system.
    Witt V; Beiglböck E; Fritsch G
    J Clin Apher; 2011; 26(4):195-9. PubMed ID: 21710651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryopreservation of human bone marrow after purging T-cells or tumor cells.
    Zhang ZX; Xu YJ; Chen Y; Li Y; Shen BF; Bai Y
    Cryobiology; 1994 Oct; 31(5):478-82. PubMed ID: 7988157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
    O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ
    Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M; Naparstek E; Slavin S
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation.
    Mahmoud H; Fahmy O; Kamel A; Kamel M; El-Haddad A; El-Kadi D
    Bone Marrow Transplant; 1999 Aug; 24(4):355-8. PubMed ID: 10467322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inverted spin method for removing RBCs from BM buffy coat products.
    Buckhalter R; Watkins K; Ericson SG
    Cytotherapy; 2003; 5(6):553-7. PubMed ID: 14660051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.